Moreover, an early diagnosis of an IR state will help public health systems by reducing future high-cost treatments (e.g., provision of T2DM patients with glucometers and strips, the use of insulin-sensitizing agents, required weight loss surgeries, pharmacological/palliative treatment for neurological disorders, etc.). Here, INS is linked to type 2 diabetes mellitus.